Julie Chezel
Creteil, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Glandular Manifestations of the Head and Neck in ANCA-Associated Vasculitides: Data from a National Cohort and Systematic Review.
Journal: Clinical reviews in allergy & immunology
Published: August 02, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 22, 2025
Soluble CD163 and incident cardiovascular events in patients with systemic lupus erythematosus: An observational cohort study.
Journal: Journal of internal medicine
Published: April 04, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
Journal: Rheumatology (Oxford, England)
Published: December 27, 2021
Primary antiphospholipid syndrome revealed by acute myocardial infarction in young adults: a prospective observational study.
Journal: Thrombosis research
Published: November 16, 2020
Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).
Journal: Rheumatology (Oxford, England)
Published: April 06, 2020
Effects of BAFF Neutralization on Atherosclerosis Associated With Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: February 05, 2020
Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
Journal: Rheumatology (Oxford, England)
Published: December 03, 2019
Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease.
Journal: Scandinavian journal of rheumatology
Published: June 05, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026